The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Gkb- nobody is forcing you to hang around. If it doesn’t fit into your trading plan then sell and move on. You sound like you’ve over exposed yourself. SNG have actually gone from focusing on COPD to pivot into a new Novel disease, complete multiple trials and currently months away from completing 2x Phase 3’s. Name any other drug that’s done that in this pandemic?
The “seamless link” for was infused agents only.
Kevin, we are awaiting the protocol release. We can’t officially move into a P3 trial that isn’t formally designed.
SNG001 is never going to treat long Covid. It hopefully prevents it in the future, but it will never be able to treat it.
CaptMinty- Why would there be no RNS tomorrow?
Woodstock, let it go. Reddit was yesterday’s conversation.
Woody- can you share a link to the information about Woodford buying?
https://www.dropbox.com/s/d591414j7ofc1pr/Photo%2022-06-2021%2C%2018%2008%2053.png?dl=0
Your reasoning is logical, but it is the original Pmjh.
Is tiptop the new citytrader? Only 41 minutes until we find out. Hopefully more of a successful guess than yesterday’s.
Woodstock, I’m sure you were screaming about having no confidence in RM only a few weeks ago. Your opinion and demands change more often than the weather, it’s difficult to keep up.
This sounds like a promising development. I look forward to hearing more about it. Hopefully the naysayers can take a break for few days, try to allow this board to have a constructive discussion.
Mr Costs, These are exactly the patients out at home trial should be targeted at. It was never ever going to be a blanket treatment, now they have focused in on the clinical requirements of a certain group. The rest will improve by themselves without intervention.
Intraday Activ news just announced, shows it can drop at anytime
I've also seen the "Source Data" I can confirm what Oak has posted is a true reflection of said source data. The caveat of these are numbers taken from multiple sources, throughout the internet and compiled into 1 best guess document also applies.
Activ 2 is a shared group of placebo. This is not a 1-1 ratio. I believe it is a group of 200 participants split amongst all drugs.
I plan on filling my full ISA allowance tomorrow morning if we don’t get results. Looking at today’s trades I’m not the only one with that thought.
Seems everyone is forgetting, in order to make a sale there must be a buyer. The shares have probably been taken by another ii.
Day 90 should land on 19th April. No doubt they will need a few days to compile and analyse data. I think we should be expecting results W/C 26th.
It looks to have already happened on 8th March. RM Was a confirmed speaker at the event. This may just be the highlight Video on Demand.